At Inventa Capital, our mission is to reimagine what’s possible in biotechnology. We are builders of what does not yet exist driven by operational rigor, visionary leadership, and a deep belief in the power of innovation. By investing in overlooked opportunities and advancing transformative science, we aim to accelerate the development of breakthrough therapies.

Remo Moomiaie-Qajar, M.D.

General Partner

Remo Moomiaie-Qajar, MD is a biotech entrepreneur, investor, and physician with over 18 years of experience founding, funding, and operating life science ventures. A Yale-trained surgeon, he has built and led multiple venture-backed companies (>$100 M raised todate), specializing in translational medicine, platform technologies, and strategic execution. As General Partner of Inventa Capital, Dr. Moomiaie-Qajar focuses on unlocking value through the acquisition and redevelopment of undervalued biotech assets, with a mission to accelerate innovation and deliver meaningful impact to patients.